>> 全站文章索引 >> 第21页:
Understanding panic attacks - [.]
Side effects of antidepressants-an overview - [Khawam EA, Laurencic G, Malone DA]
Effects of Tryptophan Depletion on the Performance of an Iterated Prisoner's Dilemma Game in Healthy Adults - [Richard M Wood1, James K Rilling2, Alan G Sanfey2, Zubin Bhagwagar3 and Robert D Rogers1]
Comparison of the Effects of Citalopram and Escitalopram on 5-Ht-Mediated Neuroendocrine Responses - [Haitham S Nadeem, Mary-Jane Attenburrow and Philip J Cowen]
Epidemiology and Outcomes of Acute lung injury - [Rubenfeld GD, Herridge MS]
Serotonin Reuptake Inhibition by Citalopram in Rat Strains Differing for Their Emotionality - [Fabrice Pollier1 MS, Sophie Sarre2 Ph.D, Sylvie Aguerre1 AS, Guy Ebinger3 MD, Pierre Mormède1 Ph.D, Yvette Michotte2 Ph.D and Francis Chaouloff1 Ph.D]
Recent advances in proton pump inhibitors and management of acid-peptic disorders - [Jain KS, Shah AK, Bariwal J, Shelke SM, Kale AP, Jagtap JR, Bhosale AV.]
Is Your Depressed Patient Bipolar - [Kaye NS.]
Effects of paroxetine on serotonin and dopamine levels in the prefrontal cortex - [K. Nakayama, N. Wakutsu and S. Ushijima 414.]
A Pilot Trial of Paroxetine for the Treatment of Hot Flashes and Associated Symptoms in Women with Breast Cancer - [Michael A. Weitzner, Joanne Moncello, Paul B. Jacobsen and Susan Minton]
Abnormal Neurotransmitter Release Underlying Behavioral and Cognitive Disorders: Toward Concepts of Dynamic and Function-Specific Dysregulation - [Martin Sarter, John P Bruno, Vinay Parikh]
The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain - [Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Slifstein M, Van Heertum RL, Mann JJ, Laruelle M]
A-85380-A Pharmacological Probe for the Preclinical and Clinical Investigation of the á4a2 Neuronal Nicotinic Acetylcholine Receptor - [Rueter LE, Donnelly-Roberts DL, Curzon P, Briggs CA, Anderson DJ, Bitner RS.]
An on-line solid phase extraction—Liquid chromatography—Tandem mass spectrometry method for the analysis of citalopram, fluvoxamine, and paroxetine in human plasma - [M. Kollroser, C. Schober]
Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic–mass spectrometric analysis - [Sarah M.R. Wille, Kristof E. Maudens, Carlos H. Van Peteghem and Willy E.E. Lambert]
A Reduced Rate of In Vivo Dopamine Transporter Binding is Associated with Lower Relative Reinforcing Efficacy of Stimulants - [Sunmee Wee1, F Ivy Carroll2 and William L Woolverton1]
Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method - [Tatsuo Shinozuka, Masaru Terada and Einosuke Tanaka]
Development and validation method for determination of Paroxetine and its metabolites by nonaqueous capillary electrophoresis in human urine. Experimental design for evaluating the ruggedness of the method - [Juana Rodríguez Flores *, Juan J. Barzas Nevado, Ana M. Contento Salcedo, Maria P. Cabello Díaz AD:Department of Analytical Chemistry and Foods Technology, Ciudad Real, Spain]
Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine - [J. Rodríguez Flores, J.J. Berzas Nevado, G. Casta?eda Pe?alvo and N. Mora Diez]
Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection - [Chien-Tsai Lai, Emily S. Gordon, Sidney H. Kennedy, Alan N. Bateson, Ronald T. Coutts and Glen B. Baker]
Measurement of total mirtazapine and normirtazapine in plasma/serum by liquid chromatography with fluorescence detection - [P. E. Morgan, J. Tapper and E. P. Spencer]
Development of a capillary gas chromatographic procedure - [J. J. Berzas, C. Guiberteau, M. J. Villase?or and V. Rodríguez]
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry - [Dorota Maciag1,4, Kimberly L Simpson2,4, David Coppinger3, Yuefeng Lu2, Yue Wang2, Rick C S Lin2 and Ian A Paul1,3]
Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia - [.]
Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma - [Hans J?rg Leis *, Werner Windischhofer, Günther Raspotnig, Günter Fauler AD:University Children]
Stir bar sorptive extraction and liquid chromatography with UV detection for determination of antidepressants in plasma samples - [Andréa Rodrigues Chaves, Silvana Maciel Silva, Regina Helena Costa Queiroz, Fernando Mauro Lan?as and Maria Eugênia Costa Queiroz]
Enantiomeric separation of the key intermediate of paroxetine using chiral chromatography - [V. V. Vivekanand, V. Ravi Kumar, Pradeep K. Mohakhud and G. Om Reddy]
A REVERSED-PHASE HPLC METHOD DEVELOPMENT FOR THE SEPARATION OF NEW ANTIDEPRESSANTS - [P. Dallet, L. Labat, M. Richard, et al.]
Ring expansion: formal total synthesis of (?)-paroxetine - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs]
A Formal Synthesis of (-)-Paroxetine by Enantioselective Ring Enlargement of a Trisubstituted Prolinol - [Janine Cossy 1 *, Olivier Mirguet 1, Domingo Gomez Pardo 1 *, Jean-Roger Desmurs 2 AD:1Laboratoire de Chimie Organique associé au CNRS, ESPCI, 10 rue Vauquelin, 75231 Paris Cedex 05, France, Fax: (internat.) + 33-(0)1407946602Rhodia, 190 avenue Thiers, 6]
High-performance liquid chromatography–mass spectrometry method for the determination of paroxetine in human plasma - [Zhimeng Zhu and Len Neirinck]
Determination of fluoxetine and its N-desmethyl metabolite in human plasma by high-performance liquid chromatography - [Laurian Vlase, Silvia Imre and Sorin Leucuta]
Public Health Advisory for Antidepressants - [Anonymous]
Suicide risk and withdrawal - [Anonymous]
Caffeine challenge in patients with panic disorder-baseline differences between those who panic and those who do not - [Masdrakis VG, Papakostas YG, Vaidakis N, Papageorgiou C, Pehlivanidis A.]
Gas chromatographic–mass spectrometric procedures for determination of the catechol-O-methyltransferase (COMT) activity and for detection of unstable catecholic metabolites in human and rat liver preparations after COMT catalyzed in statu nascendi deriva - [Hans H. Maurer, Joerg Bickeboeller-Friedrich and Thomas Kraemer]
Paxil may cool hot flashes, but it's not for kids - [Anonymous]
Monoamine depletion in psychiatric and healthy populations: review - [L Booij1, A J W Van der Does1,2 and W J Riedel3,4,5]
Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine - [D. Gervasoni, E. Panconi, V. Henninot, R. Boissard, B. Barbagli, P. Fort and P. H. Luppi]
Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans - [Linda L Carpenter, George M Anderson, Jason M Siniscalchi, Phillip B Chappell, Lawrence H Price]
Liquid chromatography–electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study - [Sonu Sundd Singh, Hiten Shah, Sapna Gupta, Manish Jain, Kuldeep Sharma, Purav Thakkar and Ruchy Shah]
Paroxetine Use Throughout Pregnancy: Does It Pose Any Risk to the Neonate - [Iris Morag, D. Batash, R. Keidar, et al.]
A new route to 3,4-disubstituted piperidines: formal synthesis of (-)-paroxetine and (+)-femoxetine - [Shinji Yamada and Ishrat Jahan]
Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters - [M. José Gómez, Mira Petrovi?, Amadeo R. Fernández-Alba and Damià Barceló]
Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes - [P. Molander, A. Thomassen, L. Kristoffersen, T. Greibrokk and E. Lundanes]
A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression - [S. Kasper and J. P. Olié]
Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons - [Annis Mechan1, Jie Yuan1, George Hatzidimitriou1, Rodney J Irvine2, Una D McCann3 and George A Ricaurte]
Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography - [Mireia Segura 1 2, Jordi Ortu?o 1, Magí Farré 1 3, Roberta Pacifici 4, Simona Pichini 4, Jesús Joglar 5, Jordi Segura 1 2, Rafael de la Torre 1 2 * AD:1Institut Municipal d]
High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum - [G. Tournel, N. Houdret, V. Hédouin, M. Deveaux, D. Gosset and M. Lhermitte]
Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression - [Francesco Benedetti, Alessandro Serretti, Cristina Colombo, Euridice Campori, et al]
Jealousy and subthreshold psychopathology: a serotonergic link. - [Marazziti D, Rucci P, Di Nasso, Masala I, Baroni S, Rossi A, Giannaccini G, Mengali F, Lucacchini A]
Diagnosing Major Depressive Disorder IX Are Patients Who Deny Low Mood a Distinct Subgroup - [Zimmerman M, McGlinchey JB, Young D, Chelminski I.]
Adult suicides linked to popular antidepressant - [Jennifer Wild]
A short formal synthesis of paroxetine. Diastereoselective cuprate addition to a chiral racemic olefinic amido ester - [Janine Cossy, Olivier Mirguet, Domingo Gomez Pardo and Jean-Roger Desmurs]
A Convenient Synthesis of (-)-Paroxetine - [László Czibula 1, András Nemes 1 *, Ferenc Seb?k 1, Csaba Szántay Jr. 2, Marianna Mák 2 AD:1Chemical Works of Gedeon Richter Ltd., Technological Research Laboratory No. I., P. O. Box 27, 1475 Budapest 10, Hungary2Chemical Works of Gedeon Richter Ltd.]
Regioselective reduction of N-alkyl-3-sulfonyl glutarimides to δ-lactams. Formal synthesis of (±)-paroxetine and (±)-tacamonine - [Chung-Yi Chen, Bo-Rui Chang, Min-Ruei Tsai, Meng-Yang Chang and Nein-Chen Chang]
Asymmetric syntheses of trans-3,4-disubstituted 2-piperidinones and piperidines - [Lee Tai Liu, Pao-Chiung Hong, Hsiang-Ling Huang, Shyh-Fong Chen, Chia-Lin Jeff Wang and Yuh-Sheng Wen]
Paroxetine Controlled Release - [Bang LM, Keating GM.]
Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders? - [Kenneth R Evans, Terrence Sills, Glen R Wunderlich and Heather P McDonald]
Adult night terrors and paroxetine - [S J Wilson, A R Lillywhite, J P Potokar, C J Bell, D J Nutt]
A reported case involving impaired driving following self-administration of xylazine - [Matthew E. Stillwell]
Development of a Capillary Zone Electrophoretic method to determine six antidepressants in their pharmaceutical preparations. Experimental design for evaluating the ruggedness of method - [Juana Rodríguez Flores *, Juan J. Berzas Nevado, Ana M. Contento Salcedo, Maria P. Cabello Díaz AD:Department of Analytical Chemistry and Foods Technology. UCLM 13071, Ciudad Real, Spain.]
Paroxetine treatment of delusional disorder, somatic type - [Hiroshi Hayashi, Shingo Oshino, Junichi Ishikawa, Shinobu Kawakatsu, Koichi Otani * AD:Department of Neuropsychiatry, Yamagata University School of Medicine, 2-2-2 Iidanishi, Yamagata 990-9585, Japan]
Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam - [isashi Tanii, Kayo Ichihashi, Ken Inoue, Kohei Fujita and Yuji Okazaki]
Syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine - [Takeshi Kubota, Akimasa Miyata]
Olanzapine versus haloperidol：acute phase results of the international double-blind olanzapine trial - [Beasley CM, Hamilton SH, Crawford AM, Dellva MA, Tollefson GD, Tran PV, Blin O, Beuzen JN.]
Serotonin syndrome in a case of depression with various somatic symptoms: The difficulty in differential diagnosis - [Takeshi Terao and Takatoshi Hikichi]
Obsessive–Compulsive Disorder - [Michael A. Jenike, M.D.]
Panic Disorder - [Wayne J. Katon, M.D.]
Social anxiety disorder - [Franklin R. Schneier, M.D.]
NMR studies of the inclusion complex between β-cyclodextrin and paroxetine - [Andrea Bernini, Ottavia Spiga, Arianna Ciutti, Maria Scarselli, Giuseppe Bottoni, Paolo Mascagni and Neri Niccolai]
Polymorphisms in the 5-Hydroxytryptamine 2A Receptor and CytochromeP4502D6 Genes Synergistically Predict Fluvoxamine-Induced Side Effects in Japanese Depressed Patients - [Yutaro Suzuki1, Kazushi Sawamura1 and Toshiyuki Someya1]
Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile: A comparison to paroxetine - [M. I. Smith, D. C. Piper, M. S. Duxon and N. Upton]
MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature - [Esther O]
Drug Metabolism Reviews 201-300 - [.]
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT1B/1D/2 receptor antagonist properties - [Ian A. Pullar, John R. Boot, Stephen L. Carney, Marlene L. Cohen, Ellen M. Colvin, Richard G. Conway, Clare H. L. Hardy, Virginia L. Lucaites, David L. Nelson, Kathryn W. Schenck, et al.]
Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXIII International Congress - [.]
ffects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow - [David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM.]
Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the wistar rat - [Eamond D. O'Loinsigh, Gerard Boland, John P. Kelly and Kathy M. O'Boyle]
Monoamine oxidase inhibition is unlikely to be relevant to the risks associated with phentermine and fenfluramine:a comparison with their abilities to evoke monoamine release - [Bermack JE, Debonnel G.]
Abstracts of the 2003 North American Congress of Clinical Toxicology Annual Meeting - [.]
An open study of paroxetine in hypochondriasis - [Desiree B. Oosterbaan, Anton J. L. M. Van Balkom, Christine A. Van Boeijen, Tim GJ De Meij and Richard van Dyck]
Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro - [Yamini Ramamoorthy, Ai-ming Yu, Nina Suh, Robert L. Haining, Rachel F. Tyndale and Edward M. Sellers]
Quantitative Analysis for Estimating Binding Potential of the Brain Serotonin Transporter With [11C]McN5652 - [Yoko Ikoma*,?,?, Tetsuya Suhara?,?, Hinako Toyama§, Tetsuya Ichimiya?,?, Akihiro Takano?,?, Yasuhiko Sudo?,?, Makoto Inoue?,?, Fumihiko Yasuno?,? and Kazutoshi Suzuki?,?]
British drug company to put data online as criticism mounts - [Jim Giles]
Is A Single Dose of MDMA Harmless - [Franz X Vollenweider, Alex Gamma, Matthias Liechti, Theo Huber]
Hypothalamic–pituitary–adrenal(HPA) system activity in depression and infection with Borna disease virus and Chlamydia pneumoniae - [M Deuschle, L Bode, P Schnitzler, U Meyding-Lamad??, A Plesch, H Ludwig, B Hamann, I Heuser]
Spitzer sues drug giant for deceiving doctors - [Meredith Wadman]
Method of treatment must be specific - [.]
Response☆ - [Pierre Blier, Julie Turcotte, Chantal H??bert, Guy Debonnel]
The pharmacogenomics of depression - [J Licinio, M-L Wong]
a question of silence - [.]
Disclosure of Clinical Trials in Children - [Maurizio Bonati, Chiara Pandolfini, and Antonio Clavenna]
FDA Weighs Suicide Risk in Children on Antidepressants - [Constance Holden]
Reward for Persistence in Substance P Research - [Claes Wahlestedt]
Cognitive Inflexibility After Prefrontal Serotonin Depletion - [H. F. Clarke, J. W. Dalley, H. S. Crofts, T. W. Robbins, and A. C. Roberts]
DRUG SAFETY:Conflict-of-Interest Allegations Derail Inquiry Into Antidepressant's 'Dark Side' - [Daniel Bachtold]
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors - [Mark S. Kramer, Neal Cutler, John Feighner, Ram Shrivastava, John Carman, John J. Sramek, Scott A. Reines, Guanghan Liu, Duane Snavely, Edwina Wyatt-Knowles, Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Christopher J. Swain, Timothy Harrison, Raymon]
Tough Placebo Rules LeaveScientists Out in the Cold - [Cassio Leite Vieira]
Future Brightening for Depression Treatments - [Constance Holden]
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [21] 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |